350 related articles for article (PubMed ID: 10070961)
1. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.
Rousselot P; Labaume S; Marolleau JP; Larghero J; Noguera MH; Brouet JC; Fermand JP
Cancer Res; 1999 Mar; 59(5):1041-8. PubMed ID: 10070961
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner.
Wang ZG; Rivi R; Delva L; König A; Scheinberg DA; Gambacorti-Passerini C; Gabrilove JL; Warrell RP; Pandolfi PP
Blood; 1998 Sep; 92(5):1497-504. PubMed ID: 9716575
[TBL] [Abstract][Full Text] [Related]
3. Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines.
König A; Wrazel L; Warrell RP; Rivi R; Pandolfi PP; Jakubowski A; Gabrilove JL
Blood; 1997 Jul; 90(2):562-70. PubMed ID: 9226155
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
[TBL] [Abstract][Full Text] [Related]
5. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.
Chen GQ; Shi XG; Tang W; Xiong SM; Zhu J; Cai X; Han ZG; Ni JH; Shi GY; Jia PM; Liu MM; He KL; Niu C; Ma J; Zhang P; Zhang TD; Paul P; Naoe T; Kitamura K; Miller W; Waxman S; Wang ZY; de The H; Chen SJ; Chen Z
Blood; 1997 May; 89(9):3345-53. PubMed ID: 9129041
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide is effective in the treatment of multiple myeloma in SCID mice.
Rousselot P; Larghero J; Labaume S; Poupon J; Chopin M; Dosquet C; Marolleau JP; Janin A; Brouet JC; Fermand JP
Eur J Haematol; 2004 Mar; 72(3):166-71. PubMed ID: 14962234
[TBL] [Abstract][Full Text] [Related]
7. An exploratory investigation of the effect of arsenic trioxide on anti-Gal antibody production in baboons.
Gollackner B; Ryan D; Knosalla C; Basker M; Alwayn IP; Harper D; Salomon G; Mauiyyedi S; Correa L; Thall A; Cooper DK
Xenotransplantation; 2003 Jan; 10(1):80-7. PubMed ID: 12535229
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide and promyelocytic leukemia protein-adenovirus synergistically inhibit in vitro and in vivo growth of a hepatoma cell line.
Cui L; Zhang S; Zhang W; Hu Z; Cao Z; Li T
Oncol Res; 2010; 18(7):305-14. PubMed ID: 20377131
[TBL] [Abstract][Full Text] [Related]
10. Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1.
Chelbi-alix MK; Bobé P; Benoit G; Canova A; Pine R
Oncogene; 2003 Dec; 22(57):9121-30. PubMed ID: 14668793
[TBL] [Abstract][Full Text] [Related]
11. RIP kinase is involved in arsenic-induced apoptosis in multiple myeloma cells.
Bajenova O; Tang B; Pearse R; Feinman R; Childs BH; Michaeli J
Apoptosis; 2004 Sep; 9(5):561-71. PubMed ID: 15314284
[TBL] [Abstract][Full Text] [Related]
12. Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines.
Lu M; Levin J; Sulpice E; Sequeira-Le Grand A; Alemany M; Caen JP; Han ZC
Exp Hematol; 1999 May; 27(5):845-52. PubMed ID: 10340400
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY
Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458
[TBL] [Abstract][Full Text] [Related]
14. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms.
Zhang W; Ohnishi K; Shigeno K; Fujisawa S; Naito K; Nakamura S; Takeshita K; Takeshita A; Ohno R
Leukemia; 1998 Sep; 12(9):1383-91. PubMed ID: 9737686
[TBL] [Abstract][Full Text] [Related]
15. Importance of ERK activation in As2O3-induced differentiation and promyelocytic leukemia nuclear bodies formation in neuroblastoma cells.
Petit A; Delaune A; Falluel-Morel A; Goullé JP; Vannier JP; Dubus I; Vasse M
Pharmacol Res; 2013 Nov; 77():11-21. PubMed ID: 24004656
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of leukemic T-cell lines to arsenic trioxide cytotoxicity is dependent on the induction of phosphatase B220/CD45R expression at the cell surface.
Benbijja M; Mellouk A; Bobé P
Mol Cancer; 2014 Nov; 13():251. PubMed ID: 25410152
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mitogen-activated protein kinase kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF-7 cells.
Ye J; Li A; Liu Q; Wang X; Zhou J
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1042-8. PubMed ID: 16445569
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C).
Michel L; Dupuy A; Jean-Louis F; Sors A; Poupon J; Viguier M; Musette P; Dubertret L; Degos L; Dombret H; Bachelez H
J Invest Dermatol; 2003 Oct; 121(4):881-93. PubMed ID: 14632209
[TBL] [Abstract][Full Text] [Related]
19. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
[TBL] [Abstract][Full Text] [Related]
20. Arsenic metabolism in multiple myeloma and astrocytoma cells.
Falnoga I; Slejkovec Z; Pucer A; Podgornik H; Tusek-Znidaric M
Biol Trace Elem Res; 2007 Apr; 116(1):5-28. PubMed ID: 17634624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
